RxDoctor Payments Data

Jena Schellhammer

Physician Assistant · Altoona, PANPI 1194950535

Payments from drug & device makers

$1,887in general payments, 2019–2025

Across 111 payments — averaging $17.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$506
  • GSK$291
  • Lilly USA, LLC$268
  • Biohaven Pharmaceutical Holding Company Ltd.$132
  • Pfizer$90
  • Tactile Systems Technology Inc$88
  • plus $513 from 10 others

What the payments were for

  • Food & beverage$1,887100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,887 in reported general payments places this provider in the 85th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$2,661
Medicare patients
27
Services billed
29

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter41$31,922
JardianceEmpagliflozin35$26,245
TrulicityDulaglutide27$24,538
EliquisApixaban13$7,792
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$4,585
Albuterol Sulfate HfaAlbuterol Sulfate40$2,070
Gabapentin48$1,049
Pantoprazole Sodium67$815
Omega-3 Acid Ethyl Esters19$737
Trazodone Hcl31$673
Atorvastatin Calcium67$578
Lisinopril69$516
Levothyroxine Sodium37$470
Omeprazole33$455
Amlodipine Besylate67$445

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$291$31,92241 claims
Boehringer IngelheimJardiance$60$26,24535 claims
Lilly USA, LLCTrulicity$268$24,53827 claims
PfizerEliquis$90$7,79213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Altoona

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →